大湾区慢性创面医护康标准化体系建设联盟,《中国科技论文》体表外科卷编辑委员会,黄广涛1,吴 军1,郇京宁1,2
(1.深圳大学第一附属医院(深圳市第二人民医院)烧伤整形科,广东深圳518000;2.上海交通大学医学院附属瑞金医院烧伤整形与创面修复科,上海200011)
摘要:负压封闭引流技术(negative pressure wound therapy, NPWT)自2017年国内首部烧伤外科应用专家共识发布以来,其技术类型与临床应用范围均取得了显著拓展。特别是在促进各类急慢性创面愈合及预防外科手术部位感染方面,已累积了大量高质量循证证据。为整合国内外最新研究成果与临床实践经验,规范操作标准,提升治疗水平,国内创面修复相关多学科领域的专家共同撰写了本更新版共识。本共识汇聚了国内多位在创面相关的多学科领域的专家,结合国内外最新研究成果,遵循严谨的循证医学原则,采用系统综述方法,聚焦于NPWT的技术分类、适应症、参数优化及并发症处理等核心议题。工作小组系统检索了PubMed、Web of Science、IEEE Xplore及中国知网等数据库中2015—2025年相关文献,共获得791篇。经去重、筛选,并根据纳入标准(临床研究、随机对照试验、meta分析及相关共识等)最终纳入210篇文献进行证据综合与评价。本共识旨在为创面修复相关学科的临床医生提供基于最新证据、统一且可操作的治疗方案与技术规范。共识内容充分结合了我国临床实践的现状与需求,以期推动NPWT在国内的合理、规范及高效应用,最终惠及广大患者。
关键词:负压封闭引流技术;手术部位感染;创面修复;手术切口并发症
Yesica Y. Quiroz 1 , Enver Moncada 2 , Erika Llorens 3 , Ivan Schwartzmann 4 , Jorge Caffarati 5 , Anna Bujons *
Summary
Introduction
Paratesticular sarcoma is an aggressive malignant tumor of mesenchymal origin. The rhabdo-myosarcoma is the most common among children. Rhabdomyosarcoma treatment consists of surgery, chemotherapy and radiotherapy. Prognosic depends on local recurrence and distant metastasis.
Material and methods
We present the case of a 16-year-old male, who in April 2016 underwent right radical orchiectomy surgery by testicular mass rapidly evolving, with pathological results indicating a paratesticular rhabdomyosarcoma. The extension study showed a precaval adenopathy suggestive of lymph node metastasis, therefore it was a high-grade rhabdomyosarcoma. There was an appropriate response after chemotherapy (Protocol EpSSG RMS2005) and we decided to perform a robotic.
Results
We performed a transperitoneal approach with 8 mm trocar and 12 mm optica trocar. We accessed the retroperitoneal space through a latero-colic incision. Then we performed a craniocaudal lymph node dissection until the aortic bifurcation. The surgical time was 240 min with a blood loss of 200 ml. There were no complications. The patient was discharged on the fourth day after surgery. Pathology showed metastasis of rhabdomyosarcoma without capsular rupture. After two months, we placed the left testicle into inguinal canal prior to radiotherapy.
Conclusions
Robotic lymph node metastasis lymphadenectomy from paratesticular sarcomas is a feasible treatment with the advantage of minimally invasive surgery and acceptable morbidity.
Wei He
Peng Liu
Hong-Lin Chen
Pressure Ulcer
surgical patients
Braden Scale
predictive validity
meta-analysis
Issue: Volume 58 - Issue 2 - February 2012
Index: Ostomy Wound Manage. 2012;58(2):34‚40.
Login or Register to download PDF
The validity and reliability of the Braden Scale for pressure ulcer development has been established in a variety of patient care settings, but studies suggest the scale does not capture risk factors in surgical patients. The purpose of this meta-analysis was to assess the predictive validity of the Braden Scale for pressure ulcer development in surgical patients. A literature search using PubMed and Web of Science databases (through July 2011) was conducted to identify all clinical studies on predicting pressure ulcers in surgical patients using the Braden Scale. To be eligible for inclusion, studies had to include sensitivity (true positive rate, TPR) and specificity (true negative rate, TNR) results or include sufficient data to calculate these factors. Study quality was assessed using the 14-item Quality Assessment of Diagnostic Accuracy Studies (QUADAS) instrument, and two-by-two tables of predictive validity were constructed from each article. Meta-analysis for predictive validity was performed, including calculation of pooled sensitivity, pooled specificity, diagnostic odds ratio (DOR), construction of summary receiver operating characteristic (SROC) curves, and overall diagnostic accuracy (Q*). Three studies (N = 609 patients) met the meta-analysis inclusion criteria. The pooled estimates for sensitivity and specificity were 0.42 (95% CI: 0.38 to 0.47) and 0.84 (95% CI: 0. 83 to 0.85), respectively, yielding a combined DOR of 4.40 (95% CI: 2.98 to 6.50). The area under the ROC curve (AUC) was 0.6921 ± 0.0346, and the Q* was 0.6466 ± 0.0274. Significant heterogeneity was noted between the included studies with Q value 34.49 (P = 0.0321), and I2 for pooled sensitivity, pooled specificity, and pooled DOR was 88.7%, 98.6%, and 39.1%, respectively. Although the observed heterogeneity between studies may have affected the results, the low values for overall diagnostic accuracy (Q*) and diagnostic capability (AUC) indicate the Braden Scale has low predictive validity for pressure ulcer risk in surgical patients. A new pressure ulcer risk assessment scale for surgical patients should be developed and tested.
Potential Conflicts of Interest: none disclosed
The patient who undergoes a long, complicated surgery is potentially at risk for developing pressure ulcers. Results of a nationwide survey1 in the US showed an overall pressure ulcer incidence for surgical patients of 8.5% (95% confidence interval: 6.1% to 10.9%). The situation is similar in other countries, with prevalence rates ranging from 14.3% to 21.2%.2,3 The most common procedures complicated by pressure ulcers are cardiac, general/thoracic, orthopedic, and vascular surgery.1
Pressure ulcers are painful, prolong patient hospital stay, and may generate significant additional costs.4,5 The first step in the pressure ulcer prevention process is risk assessment to identify both the patients who require preventive measures and the specific factors that put them at risk. The most widely used risk assessment scales are the Braden Scale, the Norton Scale, and the Waterlow Scale.6,7 A systematic review6 indicated that the Braden Scale offers the best balance between sensitivity and specificity and the best risk estimate and that the Braden Scale is more accurate than nurses’ clinical judgment in predicting pressure ulcer risk.
The Braden Scale evaluates the risk of skin breakdown in six domains: sensory perception, moisture, activity, mobility, nutrition, and friction and shear. It was developed more than 20 years ago for patients in acute and long-term-care settings.8 Subsequently identified risk factors for intraoperative pressure ulcer risk, including patient age, length of surgery, type of surgery, and comorbidities such as diabetes, preoperative hypertension, respiratory disease, and vascular disease1 are not included in the Braden Scale. The results of a descriptive study9 suggest the scale is not effective for determining pressure ulcer risk in surgical patients. However, the predictive validity of the Braden Scale for pressure ulcers in surgical patients has not been systematically reviewed.
The predictive validity of a test is determined by its sensitivity (also called true positive rate, TPR) and specificity (also called true negative rate, TNR). Sensitivity and specificity can be graphically represented by the receiver operating characteristic (ROC) curve that plots the TPR (sensitivity) against the false-positive rate (1-specificity).10 Based on data from a meta-analysis, the pooled sensitivities, pooled specificities, diagnostic odds ratios (DOR), summary receiver operating characteristic (SROC) curve, and overall diagnostic accuracy (Q*) have been recommended to represent the performance of predictive validity.11
The purpose of this meta-analysis was to assess the predictive validity of the Braden Scale for pressure ulcer development in surgical patients.
Literature search strategy. A literature search was conducted to identify studies published in PubMed and Web of Science databases before July 2011 that evaluated the predictive validity of the Braden Scale for pressure ulcer development in surgical patients. Search terms, used alone or in combination, included sensitivity, specificity, accuracy, predictive value, ROC, likelihood ratio, pressure ulcer, surgical procedures, operative, and Braden. The “related articles” function in PubMed and the “citing articles” or “cited articles” function in Web of Science also were used to broaden the search.
Inclusion and exclusion criteria. All studies that met the following criteria were included: assesses the predictive validity of Braden Scale for pressure ulcers in surgical patients; provides sufficient information to construct the two-by-two contingency tables for individual study subjects; and includes actual sensitivity (TPR) and specificity (TNR) results or includes sufficient data to calculate these factors. Two reviewers independently judged study eligibility while screening the citations. Disagreements were resolved by a third reviewer.
Data extraction. To extract data, a standard form was created that included the following variables: author, year of publication, country in which the study was conducted, study design, population and number of patients, age, duration of follow-up (eg, postoperative days 1,3, and 5), and pressure ulcer prevalence. The cutoff value used for the index test (Braden Scale score) and TPR, TNR, false negative, and false positive numbers also were collected to facilitate construction of the two-by-two tables. Two reviewers independently assessed the quality of studies using the 14-item Quality Assessment of Diagnostic Accuracy Studies (QUADAS) instrument.12 Disagreements were resolved by a third reviewer.
Statistical analysis. The overall pooled sensitivity, specificity, and DOR, with 95% confidence intervals (CI), were estimated by DerSimonian and Laird’s random-effects model.13 In addition, SROC analysis was performed to examine the interaction between sensitivity and specificity14 and to quantify test performance using the area under the curve (AUC) and Q* value.13 Heterogeneity was analyzed by Cochran’s Q test and I2 statistic. A P value of <0.05 by Cochran’s Q test indicated significant heterogeneity; an I2>50% indicated substantial heterogeneity. Threshold analyses by Spearman correlation between Logit (TPR) and Logit (1- TNP) also were performed. All analyses were performed using Meta DiSc 1.4 (version 0.6, a program developed by a Unit of the Clinical Biostatistics Team, Ramon y Cajal Hospital, Madrid, Spain).15
Literature search. During the first literature search, two English-language publications9,17 were retrieved from PubMed and three from Web of Science; of those, only one16 was used. One was excluded because the study population included patients admitted to surgical and internal medicine, as well as to neurology and geriatric wards; and the other did not meet the meta-analysis inclusion criteria because the sample included patients in medical and infectious disease wards. No publications were identified, added, or excluded after broadening the search criteria, leaving a sample of three studies (N = 609 patients) for inclusion in this meta-analysis.9,16,17 (see Table 1). The quality of all three studies was good; 90% of the 14 QUADAS items received a yes score (see Table 2).
Statistical data synthesis. The pooled sensitivity for the three studies was 0.42 (95% CI: 0.38 to 0.47; c2(21) = 185.57, P = 0.000), indicating the probability that the test result will be positive when applied to a person who actually developed a pressure ulcer was 42% (see Figure 1a). The pooled specificity was 0.84 (95% CI: 0. 83 to 0.85; c2(21) = 1501.04, P = 0.000) (see Figure 1b). The pooled DOR was 4.40 (95% CI: 2.98 to 6.50) (see Figure 1c). The SROC curve for all three studies is shown in Figure 1d. The overall weighted AUC was 0.6921 ± 0.0346, and the overall diagnostic accuracy (Q*) was 0.6466 ± 0.0274. The low AUC and a Q* of <0.7 suggest the Braden Scale has low predictive validity for pressure ulcer development in surgical patients.18
Study heterogeneity. The Cochran’s Q test value was 34.49 (P = 0.0321). I2 for pooled sensitivity, pooled specificity, and pooled DOR was 88.7%, 98.6%, and 39.1%, respectively. The results showed significant heterogeneity between the studies. Threshold analyses showed heterogeneity came from the Braden cut-off score (ie, the diagnostic threshold (Spearman correlation coefficient: 0.875, P= 0.000).
During surgery, patients are immobile and not able to feel pain caused by prolonged pressure on the operating table. Shear and friction injury also can occur as patients are repositioned and transferred. Some patients cannot be turned for extended periods of time due to postoperative use of balloon pumps or other devices.1 These and other factors may cause pressure ulcers in surgical patients. The Braden Scale is a good instrument for predicting pressure ulcer risk in acute care and long-term care settings, and often is used in surgical settings.19,20
A meta-analysis7 of the Braden Scale for assessing pressure ulcer risk among clinical settings showed that Braden and Norton scales are more accurate than nurses’ judgment in predicting pressure ulcer risk. In the current study, the authors used the meta-analysis method for diagnostic tests to assess predictive validity in order to ascertain the predictive validity assessed not only by pooled sensitivity and specificity, but also by SROC, AUC, and Q* value. This approach provides information for each cut-off point and is a comprehensive method to evaluate predictive validity.
The current meta-analysis included three publications with sample sizes ranging from 53 to 337 patients. The quality of these three studies, as evaluated using the QUADAS instrument for assessing the quality of diagnostic studies, was good, with 90% of items receiving a yes rating.10 A summary score estimating the overall quality of an article was not calculated, because the interpretation of such summary scores is problematic and potentially misleading.21
In this meta-analysis, the pooled sensitivity (TPR) was 0.42 (95% CI: 0.38 to 0.47), and the pooled specificity (TNP) was 0.84 (95% CI: 0. 83 to 0.85). Such results imply that the probability that the test result will be positive when the test is applied to a person who developed a pressure ulcer was 42%, and the probability that the test result will be negative when the test is applied to a person who actually does not develop a pressure ulcer was 84%. The predictive validity was poor, especially for the TPR. The overall weighted AUC in this meta-analysis was 0.6921 ± 0.0346. An AUC value of 0.5 indicates that a test has no discriminatory ability, whereas an AUC value of 1.0 indicates perfect diagnostic capability.22 Others have suggested that, to demonstrate excellent accuracy, the AUC should be in the region of 0.97 or above; an AUC of 0.93 to 0.96 is very good; 0.75 to 0.92 is good; but an AUC less than 0.75 has obvious deficiencies in its diagnostic accuracy.23 The result showed that the Braden Scale has low predictive validity for pressure ulcer in surgical patients.
Q* has been suggested as a single number summarization of predictive validity, being the point closest to the ideal top-left corner of the SROC space for symmetric curves. Q* is the point on the SROC where TPR =1−FPR.11 The higher the Q* value, the better the accuracy of predictive validity. When Q* is <0.7, predictive validity is poor.24 The Q* in this meta-analysis was 0.6466 ± 0.0274, suggesting that the Braden Scale cannot be used alone for predicting pressure ulcer development in surgical patients or that a new pressure ulcer risk assessment should be developed for surgical patients.
The current meta-analyses has some limitations. First, it included only three studies with a total of 609 patients. This small sample size may have affected predictive validity. Second, the results showed a significant heterogeneity between the studies. Threshold effect in the meta-analysis was noted. This heterogeneity could be the result of variations in patient assessment time differences, actual pressure ulcer prevalence rates, or the Braden Scale Score cut-off value. Third, the authors did not conduct a publication bias analysis with so few studies available for inclusion. Although this could be a limitation of the meta-analysis, publication bias will not change the predictive validity very much, because the pooled diagnosis effect was too low.
A meta-analysis was conducted to assess the predictive validity of the Braden Scale score for pressure ulcer risk assessment in surgical patients. The study found that the pooled sensitivity was low (0.42 [95% CI: 0.38 to 0.47]), and the pooled specificity was high (0.84 [95% CI: 0. 83 to 0.85]), indicating that scale score is specific but not very sensitive. In addition, both the overall weighted AUC and Q* value, calculated to determine diagnostic accuracy and predictive validity, were low (0.6921 ± 0.0346 and 0.6466 ± 0.0274, respectively). The results suggest that the Braden Scale has low predictive validity for assessing pressure ulcer risk in surgical patients. Thus, it cannot be used alone to predict pressure ulcer risk in these patients, and a new pressure ulcer risk assessment scale for surgical patients should be developed and tested.
The authors are Principal Lecturers in Nursing, School of Nursing, Nantong University, Nantong, Jiangsu PR China. Please address correspondence to: Hong-Lin Chen, MSc, Nantong University, Qi Xiu Road 19#, Nantong City, Jiangsu Province, 226001 China PR; email: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。.
伤口世界平台生态圈,以“关爱人间所有伤口患者”为愿景,连接、整合和拓展线上和线下的管理慢性伤口的资源,倡导远程、就近和居家管理慢性伤口,解决伤口专家的碎片化时间的价值创造、诊疗经验的裂变复制、和患者的就近、居家和低成本管理慢性伤口的问题。
2019广东省医疗行业协会伤口管理分会年会
扫一扫了解详情:
任何关于疾病的建议都不能替代执业医师的面对面诊断。所有门诊时间仅供参考,最终以医院当日公布为准。
网友、医生言论仅代表其个人观点,不代表本站同意其说法,请谨慎参阅,本站不承担由此引起的法律责任。